FDA grants nivolumab accelerated approval for MSI-H or dMMR colorectal cancer

01 Aug 2017 4:35 PM | Lori Aubrey (Administrator)

FDA grants nivolumab accelerated approval for MSI-H or dMMR colorectal cancer

FDA Approvals

Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org

This website brought to you by:


Powered by Wild Apricot Membership Software